Philippe Zaoui

4.4k total citations
66 papers, 1.6k citations indexed

About

Philippe Zaoui is a scholar working on Nephrology, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Philippe Zaoui has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 15 papers in Hematology and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Philippe Zaoui's work include Chronic Kidney Disease and Diabetes (16 papers), Dialysis and Renal Disease Management (12 papers) and Erythropoietin and Anemia Treatment (7 papers). Philippe Zaoui is often cited by papers focused on Chronic Kidney Disease and Diabetes (16 papers), Dialysis and Renal Disease Management (12 papers) and Erythropoietin and Anemia Treatment (7 papers). Philippe Zaoui collaborates with scholars based in France, United States and United Kingdom. Philippe Zaoui's co-authors include Raymond M. Hakim, D Cordonnier, N. Pinel, Claire Barro, Jonathan Himmelfarb, Diane Holbrook, Françoise Morel, Stéphanie Ragot, Ronan Roussel and Pierre‐Jean Saulnier and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes Care and Biochemical and Biophysical Research Communications.

In The Last Decade

Philippe Zaoui

62 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Zaoui France 20 694 401 292 239 195 66 1.6k
Tian‐Biao Zhou China 24 520 0.7× 626 1.6× 237 0.8× 217 0.9× 157 0.8× 144 1.9k
J. Floege Germany 17 1.0k 1.5× 611 1.5× 157 0.5× 274 1.1× 143 0.7× 32 2.1k
Kyung Hwan Jeong South Korea 22 703 1.0× 445 1.1× 212 0.7× 151 0.6× 87 0.4× 129 1.7k
Leopoldo Ardiles Chile 15 554 0.8× 396 1.0× 197 0.7× 214 0.9× 69 0.4× 56 1.4k
Christine K. Abrass United States 24 537 0.8× 434 1.1× 246 0.8× 176 0.7× 61 0.3× 44 1.6k
Manuel Macı́a Spain 16 485 0.7× 199 0.5× 154 0.5× 221 0.9× 83 0.4× 35 1.2k
Jianwei Tian China 24 605 0.9× 506 1.3× 106 0.4× 191 0.8× 81 0.4× 66 1.5k
Tetsuya Mitarai Japan 17 503 0.7× 304 0.8× 291 1.0× 375 1.6× 73 0.4× 54 1.3k
Weijie Yuan China 25 402 0.6× 773 1.9× 210 0.7× 115 0.5× 88 0.5× 102 2.0k
Hirotaka Fukasawa Japan 21 489 0.7× 608 1.5× 140 0.5× 199 0.8× 55 0.3× 60 1.4k

Countries citing papers authored by Philippe Zaoui

Since Specialization
Citations

This map shows the geographic impact of Philippe Zaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Zaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Zaoui more than expected).

Fields of papers citing papers by Philippe Zaoui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Zaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Zaoui. The network helps show where Philippe Zaoui may publish in the future.

Co-authorship network of co-authors of Philippe Zaoui

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Zaoui. A scholar is included among the top collaborators of Philippe Zaoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Zaoui. Philippe Zaoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rovin, Brad H., Pierre Ronco, Jack F.M. Wetzels, et al.. (2024). Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy. Kidney International Reports. 9(9). 2635–2647. 12 indexed citations
3.
4.
Brunet, Philippe, Gabriel Choukroun, Bruno Moulin, et al.. (2020). Utilisation du fer en néphrologie : enquête sur les pratiques des néphrologues français. Néphrologie & Thérapeutique. 16(3). 153–157. 1 indexed citations
5.
6.
Combe, Christian, Johannes F.E. Mann, David Goldsmith, et al.. (2019). Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study. BMC Nephrology. 20(1). 81–81. 5 indexed citations
7.
8.
9.
Voelker, James R., Paul H. Berg, Matthew J. Sheetz, et al.. (2016). Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy. Journal of the American Society of Nephrology. 28(3). 953–962. 213 indexed citations
10.
Feigerlová, Eva, Pierre‐Jean Saulnier, Pierre Gourdy, et al.. (2016). Sex hormone levels are not associated with progression of renal disease in male patients with T2DM. Diabetes & Metabolism. 43(2). 140–145. 4 indexed citations
11.
Gellen, Barnabas, Nathalie Thorin‐Trescases, P. Sosner, et al.. (2016). ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients. Diabetologia. 59(11). 2321–2330. 32 indexed citations
12.
Gesualdo, Loreto, Christian Combe, Adrian Covic, et al.. (2015). Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study). International Urology and Nephrology. 47(5). 837–845. 3 indexed citations
13.
Brault, Julie, et al.. (2014). Differential impact of glucose levels and advanced glycation end-products on tubular cell viability and pro-inflammatory/profibrotic functions. Biochemical and Biophysical Research Communications. 451(4). 627–631. 15 indexed citations
14.
Zaoui, Philippe, et al.. (2013). Are Triplicate Urine Samples Necessary to Assess Albuminuria?. Nephron Clinical Practice. 122(3-4). 80–85. 4 indexed citations
15.
Imbert, B., et al.. (2012). Renal artery embolization after intravenous mercury injection. Kidney International. 82(8). 939–939. 2 indexed citations
16.
Zaoui, Philippe, et al.. (2011). Stabilité du taux d’hémoglobine : un changement de paradigme indispensable dans la prise en charge médicale. Néphrologie & Thérapeutique. 7(1). H5–H7.
17.
Monier, Frédérique, et al.. (2002). Urinary Release of 72 and 92 kDa Gelatinases, TIMPs, N-GAL and Conventional Prognostic Factors in Urothelial Carcinomas. European Urology. 42(4). 356–363. 25 indexed citations
18.
Langham, Robyn G., Darren J. Kelly, Napier M. Thomson, et al.. (2002). Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia. 45(11). 1572–1576. 184 indexed citations
19.
Cordonnier, D, Philippe Zaoui, & Serge Halimi. (2001). Role of ACE Inhibitors in Patients with Diabetes Mellitus. Drugs. 61(13). 1883–1892. 18 indexed citations
20.
Morel, Françoise, Béatrice Dewald, Sylvie Berthier, et al.. (1994). Further characterization of the gelatinase-containing particles of human neutrophils. Biochimica et Biophysica Acta (BBA) - General Subjects. 1201(3). 373–380. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tian‐Biao Zhou Breakdown of academic impact, for papers by J. Floege Breakdown of academic impact, for papers by Kyung Hwan Jeong Breakdown of academic impact, for papers by Leopoldo Ardiles Breakdown of academic impact, for papers by Christine K. Abrass Breakdown of academic impact, for papers by Manuel Macı́a Breakdown of academic impact, for papers by Jianwei Tian Breakdown of academic impact, for papers by Tetsuya Mitarai Breakdown of academic impact, for papers by Weijie Yuan Breakdown of academic impact, for papers by Hirotaka Fukasawa
Rankless by CCL
2026